Autorenfreundlich Bücher kaufen?!
Beschreibung
There are currently no studies to support the use of Ceftazidime/amikacin-based regimen as first choice empirical treatment in patients with neutropenic fever.Demonstrate that the caftazidime/amikacin regimen is not the best empirical therapeutic approach, and could be directly impacting on longer recovery time, longer hospital stay, higher costs.
Internist's view
Details
| Verlag | Our Knowledge Publishing |
| Ersterscheinung | 29. September 2023 |
| Maße | 22 cm x 15 cm x 0.4 cm |
| Gewicht | 96 Gramm |
| Format | Softcover |
| ISBN-13 | 9786206498988 |
| Seiten | 52 |
Schlagwörter
Bekannt durch
